Fesoterodine: a new agent for treating overactive bladder.

The American journal of managed care

Volumn 15, Issue 4 Suppl, 2009, Pages

  Ellsworth, Pamela ^a   Berriman, Sandra J ^a   Brodsky, Marina ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZHYDRYL DERIVATIVE; FESOTERODINE; MUSCARINIC RECEPTOR BLOCKING AGENT;

ARTICLE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; HUMAN; MULTICENTER STUDY; OVERACTIVE BLADDER; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

BENZHYDRYL COMPOUNDS; CLINICAL TRIALS, PHASE III AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; MULTICENTER STUDIES AS TOPIC; MUSCARINIC ANTAGONISTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; URINARY BLADDER, OVERACTIVE;

EID: 67049143143     PISSN: None     EISSN: 19362692     Source Type: Journal    
DOI: None     Document Type: Article

References (0)